1. EGF stimulates Cdc42-dependent translocation of SCC antigen to the plasma membrane.
- Author
-
Emoto T and Nakamura K
- Subjects
- Actins antagonists & inhibitors, Actins metabolism, Animals, Antigens, Neoplasm analysis, Antigens, Neoplasm genetics, Bridged Bicyclo Compounds, Heterocyclic pharmacology, COS Cells, Cell Membrane chemistry, Cell Membrane metabolism, Cell Movement drug effects, Chlorocebus aethiops, Cytoskeleton drug effects, Cytoskeleton metabolism, Epidermal Growth Factor genetics, Mice, Protein Transport drug effects, Serpins analysis, Serpins genetics, Signal Transduction, Thiazolidines pharmacology, Antigens, Neoplasm metabolism, Epidermal Growth Factor metabolism, Serpins metabolism, cdc42 GTP-Binding Protein metabolism
- Abstract
Squamous cell carcinoma (SCC) antigen, including intracellular serine protease inhibitors, is widely used as a laboratory marker for cancers of squamous cell origin. Clinical evidences suggest that increased tissue-expression of SCC antigen predicts an invasive phenotype of cancer cells. Herein, we demonstrated that over-expression of SCC antigen increased the rate of EGF-stimulated cell migration. In the search for the underlying molecular mechanism, we have discovered that SCC antigen was translocated to the plasma membrane upon EGF stimulation and co-localized with polymerized-actin at lamellipodia. We further showed that, co-expression of Cdc42, a downstream target of the EGF receptor, enhanced translocation of the SCC antigen, while co-expression of dominant-inhibitory Cdc42 diminished its translocation. These results suggest that EGF-Cdc42 signal regulates the translocation of SCC antigen to the plasma membrane. Lamellipodia at the leading edge might be a site of action of SCC antigen.
- Published
- 2008
- Full Text
- View/download PDF